top of page

2024 Plenary Session Webcasts

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Thursday, April 4
Day 1 Session 1

Willis C. Maddrey Distinguished Lecture on Alcohol Liver

Introduction: Steven Flamm, MD
Keynote Speaker: Mack Mitchell, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Thursday, April 4
Day 1 Session 1

Liver Transplantation: More Than Surgery

Brian Lee, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Thursday, April 4
Day 1 Session 2

Case II: Refractory HE

Presenter: Sammy Saab, MD, MPH
Panelists: Chathur Acharya, MD; Frederic Gordon, MD; Nancy Reau, MD; and Vinod Rustgi, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 3

The Continuum of Disease: Rethinking the Existing Categories and Stages

Alina Allen, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 3

Role of Non-hepatologists in the Management of Patients with NASH/MASLD

Kenneth Cusi, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 3

Drug Treatment for MASH in 2024

Manal Abdelmalek, MD, MPH

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 4

Mock Tumor Board Case 1: Weighing the Options of Surgery vs. Transplant

Neil Mehta, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 5

Navigating the Future: Emerging Therapies and Strategic Positioning in the Management of Primary Biliary Cholangitis (PBC)

Gideon Hirschfield, MA, MB, PhD, and Aparna Goel, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 5

PSC Update and Cholestatic Itch

Gideon Hirschfield, MA, MB, PhD, and Aparna Goel, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 6

Navigating Challenges in HCV Therapy: Addressing the Issues that Remain

Mark Sulkowski, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 6

HBV Case and Panel Discussion

Mindie Nguyen, MD, MAS

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Thursday, April 4
Day 1 Session 1

Management of Alcohol-Associated Hepatitis

Craig McClain, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Thursday, April 4
Day 1 Session 2

Case I: Obese Patient with NASH Cirrhosis

Presenter: Marcelo Kugelmas, MD
Panelists: Nadege Gunn, MD, CPI; Prasun Jalal, MD; Hetal Karsan, MD, and Parvez Mantry, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Thursday, April 4
Day 1 Session 2

Case III: Surgical Risk Stratification

Presenter: Marcelo Kugelmas, MD, and Sammy Saab, MD, MPH
Panelists: Ray Kim, MD, MBA; Edward Mena, MD, MBA; Santiago Munoz, MD; and Nikolaos Pyrsopoulos, MD, MBA

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 3

Use of Surrogate Markers and Algorithms to Identify High-Risk Patients and Optimize Outcomes

Rohit Loomba, MD, MHSc

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 3

Lifestyle Recommendations in Clinical Practice

Shira Zelber-Sagi, BSc, RD, PhD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 4

What's In and What's Out: Highlights and Takeaways from Updated AASLD HCC
Practice Guidelines

Laura Kulik, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Friday, April 5
Day 2 Session 4

Mock Tumor Board Case 2: Selecting the Best Treatment for Inoperable HCC

Richard Finn, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 5

Debate: What Should be used as the first-line treatment for Autoimmune Hepatitis (AIH)?

Lily Dara, MD, and Craig Lammert, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 5

Q&A/Panel Discussion

Christopher Bowlus, MD; Lily Dara, MD; Aparna Goel, MD; Gideon Hirschfield, MA, MB, PhD; Craig Lammert, MD; and Raj Vuppalanchi, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 6

Diagnosis and Management of Hepatitis E

Kenneth Sherman, MD, PhD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Saturday, April 6
Day 3 Session 6

HDV Case and Panel Discussion

Paul Martin, MD

bottom of page